|Bid||61.24 x 800|
|Ask||61.25 x 900|
|Day's Range||60.97 - 62.15|
|52 Week Range||53.91 - 74.38|
|Beta (3Y Monthly)||0.48|
|PE Ratio (TTM)||10.96|
|Earnings Date||Oct 25, 2018|
|Forward Dividend & Yield||3.20 (5.28%)|
|1y Target Est||66.89|
The Zacks Analyst Blog Highlights: Altria, Coca-Cola, PepsiCo, Constellation and Canopy Growth
Of the 19 analysts that follow Philip Morris International (PM), 52.6% recommend a “buy,” 42.1% recommend a “hold,” and 5.3% recommend a “sell.” On average, analysts have set a price target of $91.69, which represents a potential return of 11.4% from its current stock price of $82.31.
"This all has as much to do with changing consumer behavior and continuing our mission of hiring locally," says Goodwill's regional chairwoman. "Amazon has affected every retailer."
Tobacco stocks are facing an uphill battle when it comes to regulation and public perception, but one Wall Street analyst says tobacco companies have a long track record of success for investors. The Analyst ...
Can Philip Morris Outperform Analysts’ Expectations in Q3 2018? Analysts expect Philip Morris International (PM) to post third-quarter EPS of $1.28, which represents a rise of 0.4% from $1.27 in the third quarter of 2017. From the graph below, we can see that the company has outperformed analysts’ expectations in two of the last four quarters.
Can Philip Morris Outperform Analysts’ Expectations in Q3 2018? Analysts expect Philip Morris International (PM) to post third-quarter revenues of $7.16 billion, a 4.3% drop from its revenues of $7.47 billion in the third quarter of 2017. The impact of unfavorable currency and a decline in cigarette shipment volumes could reduce the company’s revenues during the quarter.
With a declining number of cigarette smokers in the United States, cigarette-makers are looking into opportunities in the fast-growing cannabis industry.
Can Philip Morris Outperform Analysts’ Expectations in Q3 2018? Philip Morris International (PM) is scheduled to announce its third-quarter earnings before the market opens on October 18. On October 12, the company was trading at $82.31, which represents a rise of 0.2% since the announcement of its second-quarter earnings on July 19. In the second quarter, which ended on June 30, Philip Morris posted adjusted EPS of $1.41 on revenues of $7.73 billion.
There’s no question the upcoming U.S. midterm election is one of the most significant near-term catalysts in the market. Here’s a look at what investors can expect from the Nov. 6 elections and which markets ...
The company says it has no deal to announce with Altria Group, after a report that the tobacco giant was taking a stake in the Canadian company.
A report that tobacco giant Altria Group Inc. ( MO) might be keen to buy a stake in marijuana firm Aphria Inc. ( APH) has sparked conflicting views from analysts about the benefits of companies expanding their businesses. In a research note, published shortly after Aphria dismissed claims that it had signed a deal with the holding company of Philip Morris USA, Stifel’s Christopher Growe wrote that tobacco companies have been wise to avoid investing in Canadian pot producers. According to Barron’s, the analyst said that leading marijuana companies are too expensive, trading on an aggregate enterprise value of around $60 billion Canadian dollars, even though their addressable market will be worth just $5 billion Canadian dollars when recreational cannabis becomes legal in Canada Oct. 17.
American tobacco producer Altria, the maker of Marlboro cigarettes, is reportedly in discussions to buy a stake in Canadian cannabis grower Aphria, which would be the first tie-up of its kind.
Altria Group, Inc. will host a live audio webcast on Thursday, October 25, 2018, at 9:00 a.m. Eastern Time to discuss its 2018 third-quarter business results. Altria will issue a press release containing its business results at approximately 7:00 a.m.
Aphria shares jumped 15 percent to C$20.06 following the Globe and Mail report, which cited unidentified sources who said Altria has expressed interest in acquiring a minority stake in the cannabis producer, although talks could still fall through. Altria shares slipped 0.3 percent to $62.91 at the close of trade in New York at 4 p.m. Leamington, Ontario-based Aphria said in a statement that it engages in discussions with potential strategic partners and investors from time to time but “there is no agreement, understanding or arrangement in place with a potential investor at this time.” Representatives for Richmond, Virginia-based Altria, the maker of the Marlboro cigarette brand and holder of a 9 percent stake in Anheuser-Busch InBev SA, declined to comment on the report.
Altria Group Inc., the biggest U.S. cigarette company, is reportedly in talks to buy a stake in Aphria Inc., one of a growing number of Canadian cannabis producers that’s attracted the attention of investors this year. The discussions were reported by the Globe & Mail on Wednesday, sending Aphria’s stock soaring 12 percent and giving it a market value of $3.5 billion. Altria, Aphria — it even sounds meant to be. Not only does this signal that Big Tobacco does, in fact, plan to stake a claim to the nascent cannabis industry, it also brings legitimacy to a hot space that some feared might turn out to be a bubble.
Marlboro maker Altria Group Inc. is in talks with Canada-based cannabis producer Aphria Inc. to potentially acquire an equity stake in the company, The Globe and Mail reported Wednesday. Aphria stock rose 14.1%. The Globe, a subscription news site, citing multiple anonymous sources, said Altria was interested in a minority stake in Aphria with the intention of acquiring a majority stake in the longer run, but the deal terms are not final. Altria and Aphria's leadership teams have met on several occasions, with the most recent talks on Monday, the Globe said, again citing anonymous sources. After the market closed, Aphria issued a statement about the report. "While Aphria engages in discussions with potential strategic partners and/or investors from time to time, the company notes that there is no agreement, understanding or arrangement in place with a potential investor at this time," the statement reads. "Aphria will advise the investment community of any material changes, if and when they occur, in accordance with applicable disclosure requirements." Aphria stock is up 1.4% this year, including Wednesday's midday gains. The S&P 500 index has gained 5.4% this year.
Marlboro maker Altria Group Inc is in talks for a stake in Canadian cannabis producer Aphria Inc , the Globe and Mail reported on Wednesday, citing multiple sources. The details of Altria's investment are still being finalized though it has expressed interest in buying a minority stake in Aphria with the intention of eventually holding a majority, the report said. Several consumer companies are looking to strike deals with Canada's cannabis companies as sales of recreational marijuana is legalized in the G-7 country, starting Oct. 17.